Dietary and Nutritional Interventions for Post-Concussion Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how diet and nutrition can aid individuals with ongoing concussion symptoms. Researchers will divide participants into three groups: one receiving dietetic counseling (dietary advice and supplements), another receiving only supplements (Omega-3, vitamin D3, and creatine monohydrate), and a third undergoing only physiotherapy. The trial seeks participants in New Brunswick who have experienced concussion symptoms for at least two weeks but no more than six months. This study will help determine if dietary changes or supplements can ease recovery alongside standard care. As an unphased trial, it offers a unique opportunity to contribute to groundbreaking research on concussion recovery through dietary changes.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It is best to consult with the trial coordinators or your doctor for guidance.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that omega-3, vitamin D, and creatine monohydrate supplements are generally safe for most people. Studies indicate that omega-3 fatty acids, such as DHA, can reduce inflammation and support brain health after a concussion, aiding in better recovery. Consuming up to 5 grams of omega-3 per day is considered safe for healthy individuals.
Vitamin D supports overall health and is well-tolerated by most people. Creatine monohydrate may reduce brain damage and maintain energy levels in the brain. These supplements are commonly used and do not typically cause major side effects in healthy adults.
Research also suggests that nutritional interventions can improve cognitive abilities and reduce anxiety and sleep problems. These findings indicate that the dietary and nutritional treatments in this study are expected to be safe and well-tolerated by participants.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for post-concussion syndrome because they combine dietary and nutritional interventions with physiotherapy, which is a fresh approach compared to typical treatments like rest and medication. The dietary intervention includes specific supplements like omega-3, vitamin D3, and creatine monohydrate, which are thought to support brain health and recovery in unique ways. This combination aims to not only address symptoms but also potentially speed up the recovery process by targeting inflammation and brain cell energy production. By integrating nutritional support with conventional therapy, these treatments offer a holistic angle that could enhance recovery outcomes for those with post-concussion syndrome.
What evidence suggests that this trial's treatments could be effective for post-concussion syndrome?
This trial will explore the effects of dietary and nutritional interventions for post-concussion syndrome. Research has suggested that certain nutrients might alleviate symptoms following a concussion. Participants in this trial may receive omega-3 fatty acids, vitamin D, and creatine, which could reduce swelling and protect the brain after an injury. Omega-3s, for instance, may decrease damage and support brain health, while creatine might enhance thinking skills and reduce long-term fatigue. Some studies also indicate that dietary changes can improve mood, memory, and sleep. Although these findings are promising, further research is needed to confirm the benefits for individuals with post-concussion syndrome.12678
Who Is on the Research Team?
Stephanie Ward Chiasson, PhD, RD
Principal Investigator
Universite de Moncton
Are You a Good Fit for This Trial?
This trial is for adults in New Brunswick, Canada, who have had post-concussive symptoms for 2 weeks to 6 months. Participants must understand English or French and be over the age of 16. It excludes those with other neurological disorders, moderate/severe brain injury history, active inflammatory bowel disease, conditions preventing physiotherapy, and pregnant or breastfeeding women.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive dietary treatments, nutritional supplements, and/or physiotherapy treatments over eight weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Dietetic counseling
- Omega-3, vitamin D3 and creatine monohydrate
- Physiotherapy treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Universite de Moncton
Lead Sponsor
New Brunswick Health Research Foundation
Collaborator